MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$88,409K
EPS
-$1.63
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
Research and development
75,460
70,047
General and administrative
17,934
17,290
Total operating expenses
93,394
87,337
Loss from operations
-93,394
-87,337
Interest income (expense), net
5,037
4,380
Other income (expense), net
-52
-1
Net loss and comprehensive loss
-88,409
-82,958
Net loss attributable to common stockholders
-88,409
-82,958
Basic EPS
-1.63
-2.46
Diluted EPS
-1.63
-2.46
Basic Average Shares
54,143,162
33,700,550
Diluted Average Shares
54,143,162
33,700,550
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to common...
-$88,409K
Net loss and
comprehensive loss
-$88,409K
Interest income
(expense), net
$5,037K
Loss from operations
-$93,394K
Other income
(expense), net
-$52K
Total operating
expenses
$93,394K
Research and development
$75,460K
General and
administrative
$17,934K
Buy us a coffee
Eikon Therapeutics, Inc. (EIKN)
Eikon Therapeutics, Inc. (EIKN)